Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of theNanoString nCountertechnology with targetedRNAsequencing

Abstract

Inflammatory gene signatures are currently being explored as predictive biomarkers for immune checkpoint blockade, and particularly for the treatment of renal cell cancers. From a diagnostic point of view, the nCounter analysis platform and targeted RNA sequencing are emerging alternatives to microarrays and comprehensive transcriptome sequencing in assessing formalin-fixed and paraffin-embedded (FFPE) cancer samples. So far, no systematic study has analyzed and compared the technical performance metrics of these two approaches. Filling this gap, we performed a headto-head comparison of two commercially available immune gene expression assays, using clear cell renal cell cancer FFPE specimens. We compared the nCounter system that utilizes a direct hybridization technology without amplification with an NGS assay that is based on targeted RNA-sequencing with preamplification. We found that both platforms displayed high technical reproducibility and accuracy (Pearson coefficient: ≥0.96, concordance correlation coefficient [CCC]: ≥0.93). A density plot for normalized expression of shared genes on both platforms showed a comparable bi-modal distribution and dynamic range. RNA-Seq demonstrated relatively larger Suranand B. Talla and Eugen Rempel share first authorship. Albrecht Stenzinger and Martina Kirchner share last authorship.

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

“…Complementing and extending these studies, we compiled a retrospective cohort of carefully clinically annotated and confirmed ALK- and EGFR-positive NSCLC, molecularly analyzed at the Heidelberg routine diagnostic laboratory [ 22 ]. We profiled routine diagnostic formalin-fixed and paraffin-embedded biopsies after mutational analysis by NGS using the NanoString nCounter technology [ 36 ]. This technology, which can be directly applied in a routine diagnostic setting and is tissue sparing, facilitates focused analysis of mRNA profiles of 770 genes with fragmented nucleic acids as input material.…”

Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer

“…A tissue surface area of approximately 50 mm 2 was used to harvest the necessary amount of RNA (~50 ng). RNA was input directly into the nCounter platform (NanoString Technologies, Seattle, WA) for the hybridization reaction [ 17 ]. Subsequent transcriptome analysis is based on the customized 289-immuno-gene panel (Supplemental Table 1 ), which includes 289 genes involved in the immune response in cancer for individual tumor samples.…”

NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis

“…NanoString nCounter is a recently developed technology combining single-molecule fluorescence imaging with highly specific and sensitive nucleic acid binding probes providing an accurate quantitative analysis of the expression of multiple genes from one sample [6]. Crucially, Nano-String molecular profiling works effectively on partially degraded and formalin-fixed, paraffin embedded (FFPE) post-mortem tissue and is robust to low-abundance RNAs, unlike other RNA sequencing technologies [7]. RNA was extracted from 2 Â 10 μm curls of FFPE tissue using the RNAStorm™ FFPE RNA extraction kit (Cell Data Sciences, Fremont, CA, USA) according to the manufacturer's guidelines.…”

“…Post-mortem tissue can also be subject to substantial degradation bias, especially as ALS patients often die in an acidotic state (due to respiratory arrest) and thus are more prone to autolysis at post-mortem. Crucially, NanoString molecular profiling works effectively on partially degraded and formalin-fixed, paraffin embedded (FFPE) post-mortem tissue and is robust to low-abundance genes, unlike other RNA sequencing technologies [7].…”